Sensing Tool Measures Lung Function over the Phone
|
By HospiMedica International staff writers Posted on 12 May 2016 |

Image: A person using SpiroCall on a phone with and without a SpiroCall whistle (Photo courtesy of the University of Washington).
A new device allows lung function to be assessed from any phone, using the voice channel to transmit the sound of the spirometry effort.
Developed by researchers at the University of Washington (UW; Seattle, USA), the SpiroCall is a service that transmits an audio signal using the standard voice telephony channel. A server receives the data of degraded audio quality, calculates clinically relevant lung function measures using multiple regression algorithms, and reports the results using an audio message, text message, or both. The researchers also found several significant usability challenges more difficult to mitigate, such as how a user holds the phone, the distance from the user’s mouth to the phone, and how wide a user opens their mouth.
The researchers therefore designed a simple, low-cost 3D printed whistle accessory, which generates vortices as the user exhales through it, changing its resonating pitch in proportion to the flow rate. The whistle does not have any moving parts and is as simple as any spirometer mouthpiece. Advantages of the whistle include more consistent acoustic properties, audible sound at lower flow rates, removing the effect of distance from the user’s mouth, and precisely controlling mouth shape and phone orientation.
In a study to investigate viability of the call-in service approach with and without the whistle, the researchers evaluated SpiroCall in 50 patients, comparing it to approved spirometers and evaluating the effect of using the voice communication channel on performance. Each patient performed spirometry efforts with and without the whistle on two different phones, recording the audio through the cell phone network, and two smartphones recording the audio locally through an app. Participants also used two different sizes of vortex whistles to determine if different sizes work better for different individuals.
The results show that without a whistle, SpiroCall has a mean error of 7.2% for the four major clinically relevant lung function measures; for forced expiratory volume percentage (FEV1%), the mean error is 6.2%. With a whistle, SpiroCall has a mean error of 8.3% for the four measures, and 7.3% for FEV1%. Although the whistle shows higher average error in lung function estimates, it is more consistent for people with lower lung function and produces fewer overestimations. The study was presented at the Association for Computing Machinery conference, held during May 2016 in San Jose (CA, USA).
"People have to manage chronic lung diseases for their entire lives, so there's a real need to have a device that allows patients to accurately monitor their condition at home without having to constantly visit a medical clinic,” said lead author Mayank Goel, MSc, a computer science and engineering doctoral student. “Because this project has been around for four years, we've been able to talk to a lot of patients about how they're able to use the technology, and that feedback has really helped us make smart improvement.”
Related Links:
University of Washington
Developed by researchers at the University of Washington (UW; Seattle, USA), the SpiroCall is a service that transmits an audio signal using the standard voice telephony channel. A server receives the data of degraded audio quality, calculates clinically relevant lung function measures using multiple regression algorithms, and reports the results using an audio message, text message, or both. The researchers also found several significant usability challenges more difficult to mitigate, such as how a user holds the phone, the distance from the user’s mouth to the phone, and how wide a user opens their mouth.
The researchers therefore designed a simple, low-cost 3D printed whistle accessory, which generates vortices as the user exhales through it, changing its resonating pitch in proportion to the flow rate. The whistle does not have any moving parts and is as simple as any spirometer mouthpiece. Advantages of the whistle include more consistent acoustic properties, audible sound at lower flow rates, removing the effect of distance from the user’s mouth, and precisely controlling mouth shape and phone orientation.
In a study to investigate viability of the call-in service approach with and without the whistle, the researchers evaluated SpiroCall in 50 patients, comparing it to approved spirometers and evaluating the effect of using the voice communication channel on performance. Each patient performed spirometry efforts with and without the whistle on two different phones, recording the audio through the cell phone network, and two smartphones recording the audio locally through an app. Participants also used two different sizes of vortex whistles to determine if different sizes work better for different individuals.
The results show that without a whistle, SpiroCall has a mean error of 7.2% for the four major clinically relevant lung function measures; for forced expiratory volume percentage (FEV1%), the mean error is 6.2%. With a whistle, SpiroCall has a mean error of 8.3% for the four measures, and 7.3% for FEV1%. Although the whistle shows higher average error in lung function estimates, it is more consistent for people with lower lung function and produces fewer overestimations. The study was presented at the Association for Computing Machinery conference, held during May 2016 in San Jose (CA, USA).
"People have to manage chronic lung diseases for their entire lives, so there's a real need to have a device that allows patients to accurately monitor their condition at home without having to constantly visit a medical clinic,” said lead author Mayank Goel, MSc, a computer science and engineering doctoral student. “Because this project has been around for four years, we've been able to talk to a lot of patients about how they're able to use the technology, and that feedback has really helped us make smart improvement.”
Related Links:
University of Washington
Latest Health IT News
- EHR Alerts Support Dosing, Sedation, and Shock Recognition in Cardiac Care
- Adaptive Radiation QA Software Gains Validation for NeoArc Treatments
- Healthcare Database Helps Close Long COVID Surveillance Gap
- Smartphone App Improves Blood Pressure Control in Hypertension
- New Tablet Platform Extends Stroke Neurorehabilitation Beyond the Clinic
- Registry-Driven Digital Outreach Boosts Use of Heart Failure Medicines
- Nurse-Coordinated Care Model Improves Heart Failure Outcomes
- Imaging Tool Quantifies Calcinosis Cutis Volume to Monitor Treatment
- Digital Symptom Monitoring Supports More Personalized Breast Cancer Care
- Short Digital Training Program Improves Motor Function in Parkinson’s Disease
- New Cloud Platform Streamlines Capsule Endoscopy Workflow and Reporting
- Smartwatch Monitoring Identifies Abnormal Vital Signs Before Routine Checks
- Weekly Remote Symptom Monitoring Improves Symptom Control in Advanced Cancer
- Digital Heart Model Supports Targeted Ablation in Atrial Fibrillation
- AI Framework Helps Clinicians Create Trustworthy Risk Prediction Tools
- AI Tool Screens for Primary Aldosteronism Using Routine EHR Data
Channels
Artificial Intelligence
view channel
AI Tool Predicts Long-Term Cardiovascular Risk from Sleep Study ECG
Sleep disorders such as insomnia and obstructive sleep apnea are established cardiovascular risk factors and are commonly evaluated with overnight polysomnography. These studies routinely record electrocardiogram... Read more
Predictive Model Supports Growth Hormone Treatment Planning in Idiopathic Short Stature
Idiopathic short stature (ISS) describes children whose height is substantially below the expected range for age and sex without an identifiable medical cause. Recombinant growth hormone therapy can support... Read moreSurgical Techniques
view channel
Contact Radiotherapy Offers New Organ-Preserving Approach for Rectal Cancer
Tampere University Hospital, known as Tays, is the first hospital in Finland to introduce contact radiotherapy for rectal cancer using high-dose-rate brachytherapy, or HDR brachytherapy.... Read more
Covered Stent System Achieves High Nine-Month Patency in Iliac Artery Disease
Iliac artery disease, a common form of peripheral artery disease, can restrict blood flow to the legs and impair mobility and quality of life. Clinicians continue to seek durable endovascular treatments... Read morePatient Care
view channel
AI Platform Personalizes Support Between Visits for Cancer Survivors
Cancer survivors often manage persistent side effects after treatment, including fatigue, anxiety, uncertainty, symptoms, stress, and questions between appointments. Clinical teams need ways to maintain... Read more
At-Home Neuromodulation Shows Promise in Selected Patients With Hypertension
High blood pressure is a major risk factor for cardiovascular disease, including heart attack and stroke. Many patients receiving treatment for hypertension still remain above recommended blood pressure... Read more
EHR Model Flags High-Risk Periods in Patients with Metastatic Breast Cancer
Determining when patients with metastatic breast cancer are nearing the end of life remains difficult, often leading to intensive interventions with limited benefit. Prognostic uncertainty can delay goals-of-care... Read moreMedical Imaging
view channel
Public Chest CT Dataset Supports Explainable AI in Diagnostic Radiology
Chest computed tomography scans generate complex three-dimensional images that can be difficult for artificial intelligence systems to explain clearly. Clinicians need to verify AI findings before using... Read more
PSMA PET/CT-Guided Biopsy Improves Detection of Significant Prostate Cancer After Nondiagnostic MRI
Prostate cancer can be difficult to detect when magnetic resonance imaging (MRI) findings are negative or inconclusive. Men with persistent clinical risk factors may still require biopsy, yet standard... Read more
AI Software Detects Osteoporosis from Routine CT Scans
Osteoporosis can progress for years without pain, leaving bone loss undetected until a fracture or back pain prompts testing. By that point, bone loss may already be advanced. Bone density testing is not... Read more
AI Model Uses Pretreatment CT Scans to Predict Immunotherapy-Related Pneumonitis Risk
Pneumonitis is a potentially life-threatening form of lung inflammation that affects about 10% of patients with lung cancer receiving immunotherapy. Because it can be difficult to predict before symptoms... Read moreHealth IT
view channel
EHR Alerts Support Dosing, Sedation, and Shock Recognition in Cardiac Care
Electronic health record alerts can add to clinician workload when they are poorly targeted. In critical cardiac care, however, delayed decisions can affect treatment timing, sedation exposure, and escalation... Read more
Adaptive Radiation QA Software Gains Validation for NeoArc Treatments
Adaptive radiation therapy allows clinicians to adjust treatment plans to daily anatomical changes such as tumor shrinkage, weight loss, or organ movement, improving precision while limiting exposure to... Read morePoint of Care
view channel
Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes
Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more
Microneedle Patch Enables At-Home Monitoring of Acute Kidney Injury
Kidney disease is often silent in its early stages, making timely detection difficult outside clinical settings. Early biomarkers such as neutrophil gelatinase–associated lipocalin can require blood draws... Read moreBusiness
view channel
Terumo Neuro Acquisition Advances Liquid Embolic Technology for Chronic Subdural Hematoma
Terumo Neuro (Aliso Viejo, CA, USA) signed an agreement to acquire Arsenal Medical Inc. (Waltham, MA, USA), a privately held, clinical-stage biomaterials company. The proposed acquisition would add NeoCast,... Read moreWorld Health Expo to Showcase Trillion-Dollar Growth Across Pharma, Biotech, Longevity and Wellness at 2027 Edition
World Health Expo (WHX) expands with the new Pharma, Biotech, Longevity and Wellness industry sectors More than 235,000 professional visits, over 4,200 exhibitors and representatives from over... Read more
Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery
As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more







